Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the immune system, a development which may prove useful in cancer immunotherapy, according to a study published in Nature Communications.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *